Source: Eur Respir J 2012; 39: 297-304
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kieninger E., Vareille M., Kopf B.S., Blank F., Alves M.P., Gisler F.M., Latzin P., Casaulta C., Geiser T., Johnston S.L., Edwards M.R., Regamey N.. Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis. Eur Respir J 2012; 39: 297-304

Member's Comments

No comment yet.

Related content which might interest you: Characterization of cystic fibrosis airway epithelium in vitro Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Mechanisms and markers of airway inflammation in cystic fibrosis Source: Eur Respir J 2002; 19: 333-340 Year: 2002 M2 polarized alveolar macrophages in pulmonary fibrosis Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 Inflammatory cytokines in airway secretions from patients with cystic fibrosis contribute to airway epithelial cell damage Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Inflammatory response upon viral infection in cystic fibrosis airway epithelial cells Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections Year: 2010 Differential interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Anti-inflammatory cytokines in cystic fibrosis lung disease Source: Eur Respir J 2006; 28: 581-587 Year: 2006 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017 Year: 2018 IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019 Year: 2021 Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Source: Eur Respir J 2008; 32: 1068-1081 Year: 2008 Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms Source: Eur Respir J 2008; 31: 396-406 Year: 2008 The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008 COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 New insights into the pathophysiology of lung disease in cystic fibrosis patients Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1 Year: 2006 Azithromycin fails to restore apoptosis in cystic fibrosis airway epithelium post viral infection Source: Annual Congress 2011 - Epithelial cells: role in health and disease Year: 2011 Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium Source: Eur Respir J 2013; 41: 1315-1323 Year: 2013 Clinical correlation of epithelial barrier dysfunction related to neutrophilic inflammation in cystic fibrosis Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019